Ranitidin-ratiopharm

Category

Ranitidin-ratiopharm




Useful info

Ranitidin-ratiopharm Brand names, Ranitidin-ratiopharm Analogs

Ranitidin-ratiopharm Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

    • Ranitidin-ratiopharm Chemical_Formula

    C13H22N4O3S

    Ranitidin-ratiopharm RX_link

    http://www.rxlist.com/cgi/generic2/ranitbc.htm

    Ranitidin-ratiopharm fda sheet

    Ranitidin-ratiopharm FDA

    Ranitidin-ratiopharm msds (material safety sheet)

    Ranitidin-ratiopharm MSDS

    Ranitidin-ratiopharm Synthesis Reference

    B. J. Price et al., U.S. Pat. 4,128,658 (1978)

    Ranitidin-ratiopharm Molecular Weight

    314.405 g/mol

    Ranitidin-ratiopharm Melting Point

    69-70 oC

    Ranitidin-ratiopharm H2O Solubility

    24.7 mg/mL

    Ranitidin-ratiopharm State

    Solid

    Ranitidin-ratiopharm LogP

    1.93

    Ranitidin-ratiopharm Dosage Forms

    Capsule; Liquid; Solution; Tablet; Syrup

    Ranitidin-ratiopharm Indication

    Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

    Ranitidin-ratiopharm Pharmacology

    Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

    Ranitidin-ratiopharm Absorption

    Approximately 50% bioavailability orally.

    Ranitidin-ratiopharm Toxicity

    LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

    Ranitidin-ratiopharm Patient Information

    PATIENT INFORMATION

    Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
    contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
    on the tongue.

    Ranitidin-ratiopharm Organisms Affected

    Humans and other mammals